Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Conducted on thousands of participants, TRIUMPH-1 demonstrated that Retatrutide could lead patients to lose up to 28.3% of their body weight at 80 weeks
Kidney transplant patients prescribed GLP-1 drugs were 49% less likely to experience organ failure, in which their new kidney stops working and they have to resume dialysis, researchers reported March 3 in The Lancet
I am interested in a monoclonal antibody specific to my target protein
It is possible to travel with your injections: When traveling by air, keep your injections with you in your carry-on with an ice pack to keep it cold
Following GLP-1 deprescription, patients weight did not significantly increase at 6 or 12 months post deprescription, compared to many well-known drug trials (in red) where patients regain up to two thirds of weight loss after discontinuing the drug
Int J Obes Relat Metab Disord 23(3):304311
